Quantifying Tumor Vascular Heterogeneity With DCE-MRI in Complex Adnexal Masses: A Preliminary Study

被引:17
|
作者
Thomassin-Naggara, Isabelle [1 ,2 ,3 ]
Soualhi, Narimane [1 ]
Balvay, Daniel [1 ,4 ]
Darai, Emile [5 ]
Cuenod, Charles-Andre [1 ]
机构
[1] INSERM, UMR970, Parc HEGP Equipe 2, Imagerie Angiogenese, Paris, France
[2] IUC, UPMC Univ Paris 06, Sorbonne Univ, Paris, France
[3] Hop Tenon, AP HP, Dept Radiol, Paris, France
[4] Univ Paris 05, Plateforme Imagerie Petit Anim, Sorbonne Paris Cite, Fac Med, Paris, France
[5] Hop Tenon, AP HP, Dept Obstet & Gynaecol, Paris, France
关键词
ovarian; adnexal masses; heterogeneity; DCE-MRI; MRI; CONTRAST-ENHANCED MRI; OVARIAN-CANCER; PERFUSION; PERMEABILITY; VALIDATION; PARAMETERS; PROSTATE; FEATURES; AIFS; LUNG;
D O I
10.1002/jmri.25707
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the value of quantifying dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) heterogeneity to characterize adnexal masses. Materials and Methods: Our database was retrospectively queried to identify all surgically proven adnexal masses characterized with a 1.5T DCE-MRI between January 1st 2008 and February 28th 2010 (n=113 masses, including 52 benign, 11 borderline, and 50 invasive malignant tumors). The solid component of the adnexal mass was segmented. Quantitative analysis with a compartmental model was performed to calculate microvascular parameters, including tissue blood flow (F-T), blood volume fraction (V-b), lag time (D-AT), interstitial volume fraction (V-e), permeability-surface area product (PS), and relative area under curve ((r)AUC), were calculated. Then heterogeneity parameters were evaluated using the analysis of the evolution of the standard deviation (SD) of signal intensities on DCE-MRI series. The area under the receiver operating characteristic (AUROC) curve was calculated to assess the overall discrimination of parameters. Results: Malignant tumors displayed higher F-T, V-b, and (r)AUC and lower D-AT than benign tumors (P=0.01, P < 0.0001, and P < 0.0001, respectively). Invasive malignant tumors displayed lower V-b and (r)AUC than borderline tumors (P < 0.01). After injection, whenever the heterogeneity parameter was considered, malignant tumors were more heterogeneous than benign tumors, invasive tumors were more heterogeneous than borderline ovarian tumors, and malignant tumors with carcinomatosis were more heterogeneous than tumors without carcinomatosis (P < 0.001). The most discriminant parameter was the SD during the 90 seconds after injection related to arterial input function (SDEARLY/AIF) with an AUROC between 0.715 and 0.808. Conclusion: This study proposes heterogeneity parameters as a new tool with a potential for clinical application, given that the technique uses routine imaging sequences.
引用
收藏
页码:1776 / 1785
页数:10
相关论文
共 50 条
  • [1] Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response
    Ashraf, Ahmed
    Gaonkar, Bilwaj
    Mies, Carolyn
    DeMichele, Angela
    Rosen, Mark
    Davatzikos, Christos
    Kontos, Despina
    [J]. TRANSLATIONAL ONCOLOGY, 2015, 8 (03): : 154 - 162
  • [2] Influence of temporal parameters of DCE-MRI on the quantification of heterogeneity in tumor vascularization
    Crombe, Amandine
    Saut, Olivier
    Guigui, Jerome
    Italiano, Antoine
    Buy, Xavier
    Kind, Michele
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 50 (06) : 1773 - 1788
  • [3] DCE-MRI as a biomarker of tumor angiogenesis
    Jayson, G.
    [J]. EJC SUPPLEMENTS, 2007, 5 (08): : 9 - 9
  • [4] Liver tumor assessment with DCE-MRI
    Caldeira, Liliana
    Sanches, Joao
    [J]. 2008 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1-4, 2008, : 804 - 807
  • [5] Radiomics in the Analysis of Breast Cancer Heterogeneity On DCE-MRI
    Li, H.
    Lan, L.
    Drukker, K.
    Perou, C.
    Giger, M.
    [J]. MEDICAL PHYSICS, 2015, 42 (06) : 3588 - 3588
  • [6] Heterogeneity of Tumor Vasculature and Antiangiogenic Intervention: Insights from MR Angiography and DCE-MRI
    Zhu, Wenlian
    Kato, Yoshinori
    Artemov, Dmitri
    [J]. PLOS ONE, 2014, 9 (01):
  • [7] Diagnostic Value of DCE-MRI for Differentiating Malignant Adnexal Masses Compared with Contrast-enhanced-T1WI
    Otani, Satoshi
    Kido, Aki
    Himoto, Yuki
    Sakata, Akihiko
    Otani, Tomoaki
    Kuwahara, Ryo
    Moribata, Yusaku
    Nishio, Naoko
    Yajima, Ryo
    Nakao, Kyoko
    Kurata, Yasuhisa
    Minamiguchi, Sachiko
    Mandai, Masaki
    Nakamoto, Yuji
    [J]. MAGNETIC RESONANCE IN MEDICAL SCIENCES, 2022, 21 (04) : 599 - 607
  • [8] Study on the Value of DCE-MRI in Differentiating Glossitis and Tongue Cancer and the Intratumour Heterogeneity
    Liu, Fenghai
    Zhao, Meng
    Lu, Shan
    Kang, Liqing
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6925 - 6934
  • [9] Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?
    Alic, L.
    van Vliet, M.
    van Dijke, C. F.
    Eggermont, A. M. M.
    Veenland, J. F.
    Niessen, W. J.
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (06): : 1601 - 1616
  • [10] Breast Tumor Segmentation in DCE-MRI With Tumor Sensitive Synthesis
    Wang, Shuai
    Sun, Kun
    Wang, Li
    Qu, Liangqiong
    Yan, Fuhua
    Wang, Qian
    Shen, Dinggang
    [J]. IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS, 2023, 34 (08) : 4990 - 5001